JAN
Janus Living, Inc. • NYSE
$25.71 ▼ -1.64% (-0.43)
JAN
Janus Living, Inc.NYSE • $25.71 ▼ -1.64% (-0.43)
Market Cap $227.79 M
52w High $26.70
52w Low $22.76
P/E -75.62
Volume 1.21M
Outstanding Shares 8.71M
Market Cap $227.79 M
52w High $26.70
52w Low $22.76
P/E -75.62
Volume 1.21M
Outstanding Shares 8.71M
About Janus Living, Inc.
https://www.janone.comJanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction.
CEO
Scott Brinker
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Waste Management
Sector Industrials
Went public March 20, 2026
Method of going public IPO
Full time employees 5
ETFs Holding This Stock
Summary
Total 20
Showing Top 2 of 20
Price Target
Target High $28
Target Low $26
Target Median $27
Target Consensus $27.25